Question 1

Are wound grafts covered by Medicare?

Accepted Answer

Yes. Skin substitute grafts (including amniotic membrane allografts) are generally covered by Medicare when applied to chronic, non-healing wounds such as diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs) that have failed at least four weeks of documented standard wound care. Coverage is driven by the patient's Medicare Administrative Contractor (MAC) Local Coverage Determination (LCD) and the corresponding Local Coverage Article (LCA), which list the specific HCPCS Q-codes that are payable in that jurisdiction. Each MAC publishes its own list of covered products, frequency limits, and documentation expectations, so the same product can be covered in one jurisdiction and non-covered in another. Reimbursement also varies by site of service — physician office (POS 11), hospital outpatient (POS 19/22), and ASC (POS 24) — because the product and application CPT (15271–15278) are bundled differently. Our team can walk you through your MAC's current policy for any product in our catalog.

Question 2

What HCPCS Q-codes apply to these graft products?

Accepted Answer

Skin substitute products are billed under HCPCS Q-codes in the Q41xx range, with each manufacturer/product combination assigned its own unique Q-code by CMS. For example, dehydrated human amnion/chorion membrane (dHACM) sheet allografts, dual-layer amniotic membranes, particulate amniotic products, and flowable amniotic injectables each carry distinct Q-codes. The Q-code is billed per square centimeter of product applied (not per graft), so accurate measurement and documentation of wastage is critical. Application is billed separately using CPT 15271–15278 based on wound surface area and anatomic site. Every product page in our catalog lists its current Q-code and ASP, and our reimbursement team keeps these synchronized with the quarterly CMS ASP file.

Question 3

How do I verify coverage with my MAC?

Accepted Answer

Start by identifying your MAC jurisdiction (Novitas, Noridian, NGS, Palmetto GBA, CGS, First Coast, or WPS) based on your practice ZIP code, then pull the active "Skin Substitute Grafts/Cellular and Tissue-Based Products for Wounds" LCD and its companion LCA. The LCA contains the actual list of covered HCPCS Q-codes — a product can be referenced in the LCD but still be non-covered if it is not on the LCA's product list. Next, check the patient's specific plan (traditional Medicare, MA, or commercial) and confirm any prior authorization, step-therapy, or conservative-care documentation requirements. We can run a benefits verification for any patient before you place a graft order — just submit the request from the quote sheet.

Question 4

Is the graft separately payable in a physician office versus hospital outpatient?

Accepted Answer

Yes — payment mechanics differ significantly. In the physician office setting (POS 11), the graft itself is paid separately under ASP + 6% (or the patient-specific contracted rate) in addition to the application CPT. In the hospital outpatient department (OPPS, POS 19/22), most skin substitutes are packaged into the application APC payment under the high-cost/low-cost skin substitute methodology — meaning the facility receives a single bundled payment that includes both the product and the application. The high-cost vs. low-cost designation is updated annually by CMS and determines which APC the case maps to. ASCs follow OPPS packaging rules. Always confirm POS-specific economics before scheduling a case.

Question 5

What documentation supports medical necessity for graft application?

Accepted Answer

At minimum, the medical record must document: (1) the wound etiology and a confirmed diagnosis (e.g., DFU with appropriate ICD-10 such as E11.621); (2) at least four weeks of failed standard wound care, including offloading for DFUs and compression for VLUs; (3) baseline and serial wound measurements (length × width × depth) with photographs where possible; (4) absence of active infection and adequate vascular supply (ABI or TBI for lower-extremity wounds); (5) the product applied, HCPCS Q-code, lot number, exact square centimeters applied, and square centimeters discarded; and (6) the patient's response at each follow-up. Most MACs also expect a comorbidity assessment (glycemic control for DFUs, venous reflux work-up for VLUs) and a clear plan of care. Templates and dot-phrases are available in our provider resources library.

Question 6

How many graft applications are typically covered per wound episode?

Accepted Answer

Most MAC LCDs allow up to 10 applications per wound per 12-week episode of care, with re-evaluation expected if the wound has not reduced in size by a clinically meaningful amount (commonly 40–50%) at the 4-week mark. Some MACs cap coverage at 8 applications, and a few apply per-patient limits across concurrent wounds. Continued application beyond the standard episode generally requires documentation of progress and a refreshed plan of care. Always check your jurisdiction's current LCD — frequency limits are one of the most common denial drivers.

Question 7

Do you provide prior authorization support for commercial payers?

Accepted Answer

Yes. Many commercial and Medicare Advantage plans require prior authorization for skin substitutes, and the requirements vary significantly by payer. Our reimbursement team will pull the patient's benefits, prepare the PA packet using your clinical notes, submit to the payer, and track to determination. We handle peer-to-peer scheduling support and provide template letters of medical necessity. This service is included for any product purchased through Kindr Wound Care.

Question 8

What happens if a claim is denied? Do you offer appeal support?

Accepted Answer

Yes. The most common denial reasons are documentation gaps (missing failed-conservative-care timeline, missing wound measurements, missing offloading note) and product/site-of-service mismatches. Our team will review the denial reason, pull the original notes, draft a redetermination or reconsideration letter, and provide supporting clinical literature. We can also assist through the second-level QIC reconsideration and ALJ hearing stages if needed. This is included with any product purchased through us — we share your interest in clean claims.

Question 9

Are there specific LCD requirements I should know about in my region?

Accepted Answer

Yes — and they change. Each MAC's "Skin Substitute Grafts" LCD specifies which Q-codes are covered, which diagnoses qualify, the required pre-application work-up (vascular, glycemic, offloading), frequency limits, and documentation requirements. Several MACs have recently issued draft LCDs that significantly tighten coverage. Tell us your MAC jurisdiction and we will send the current active LCD/LCA plus a one-page summary of the documentation expectations specific to your region.

Question 10

How does reimbursement differ for DFUs, VLUs, and pressure injuries?

Accepted Answer

DFUs and VLUs are the two wound types with the broadest skin-substitute coverage across MACs, provided the documented conservative-care period, offloading (DFUs), and compression (VLUs) requirements are met. Pressure injuries (decubitus ulcers) are covered by fewer MACs and often only at advanced stages with strict documentation of pressure-redistribution interventions and nutritional optimization. Surgical wounds, traumatic wounds, and burns each have their own coverage criteria and CPT pathways. The product economics (ASP, allowed Q-codes) are the same across wound types, but the medical-necessity bar and required documentation differ — always confirm against your MAC's LCD for the specific wound etiology.

Question 11

When should I choose an amniotic membrane graft over a collagen dressing?

Accepted Answer

Collagen dressings are typically a first-line advanced dressing for wounds in the early proliferative phase that need scaffold support but are progressing on standard care. Amniotic membrane allografts (dHACM, dual-layer, particulate, flowable) are indicated when a wound has stalled despite ≥4 weeks of appropriate standard care — they deliver growth factors, cytokines, and an extracellular matrix that can re-start the healing cascade in chronic wounds. Amniotic grafts are also preferred when granulation tissue quality is poor, the wound is in a difficult anatomic location, or you need a bioactive product rather than a passive scaffold. The right choice depends on wound chronicity, depth, exudate level, and the patient's comorbidities — our clinical team can walk a case with you.

Question 12

What wound types and depths are appropriate for each graft product?

Accepted Answer

Sheet allografts (dHACM and dual-layer) are well-suited for partial- and full-thickness wounds with a clean wound bed and definable margins — DFUs, VLUs, post-surgical dehiscence, traumatic wounds. Particulate amniotic products excel in irregular geometry, tunneling, and undermined wounds where a sheet cannot make full contact. Flowable amniotic products are designed for deep, complex, or sinus-tract wounds where injection or instillation is required. Synthetic and collagen-based substitutes are typically reserved for wounds that need scaffold support more than bioactive signaling. Each product page lists its FDA-cleared indications, contraindications, and recommended wound profile.

Question 13

How do I prepare the wound bed before graft application?

Accepted Answer

Effective wound bed preparation follows the TIME framework: Tissue debridement (sharp, enzymatic, or autolytic to remove non-viable tissue and biofilm), Infection/inflammation control (treat clinical infection before application; consider quantitative culture if recurrent), Moisture balance (manage exudate appropriately), and Edge advancement (undermine and freshen wound margins). The wound should be free of slough, eschar, and clinical infection at application. The bed should be moist but not macerated. Hemostasis must be achieved before placing the graft. Specific prep recommendations for each product are in its IFU and in our application guides.

Question 14

What are the signs of graft take versus graft failure?

Accepted Answer

Successful graft take is generally evidenced by adherence of the graft to the wound bed within 48–72 hours, progressive incorporation, healthy granulation around and beneath the graft, decreasing wound surface area at the 1- and 2-week reassessments, and absence of clinical infection. Signs of graft failure or non-response include persistent graft mobility, purulent drainage, increasing erythema or pain, wound enlargement, and lack of measurable wound area reduction at the 4-week mark. Most protocols reassess at 7 days for graft adherence and weekly thereafter, with measurement and photography at every visit. Lack of a clinically meaningful response by week 4 should prompt a re-evaluation of etiology, vascular supply, infection status, and product selection.

Question 15

How do you train our clinical staff on proper application techniques?

Accepted Answer

We offer manufacturer-developed in-service training for every product we distribute, delivered on-site or virtually by a clinical specialist. Sessions cover product handling, wound bed prep, sizing, application, securement, dressing strategy, and reassessment cadence. We also provide printed quick-reference cards, video walkthroughs, and a clinical specialist line you can call during a case. New ordering clinics get a complimentary onboarding session before their first application.

Question 16

Do you offer in-service education for our wound care team?

Accepted Answer

Yes. We offer in-service sessions covering product portfolios, application techniques, documentation best practices, MAC-specific LCD requirements, and case-based clinical discussions. CME-eligible content is available through select manufacturer partners. Sessions can be scheduled by your account representative.

Question 17

Can your clinical team help with wound measurement and documentation?

Accepted Answer

Yes. We provide measurement tools (acetate tracings, digital planimetry references), documentation templates aligned to MAC LCD expectations, and dot-phrases for major EHRs. Our clinical specialists can sit chair-side for a session to review your workflow and identify documentation gaps that commonly trigger denials. Strong measurement and documentation is the single highest-leverage thing a practice can do to protect reimbursement.

Question 18

What are the contraindications for these graft products?

Accepted Answer

General contraindications across the amniotic graft category include active clinical infection at the wound site, exposed bone or hardware without prior debridement and culture, untreated osteomyelitis, malignancy in the wound bed, inadequate arterial perfusion (typically ABI < 0.5 or absent pedal Doppler signals), and known hypersensitivity to any product component. Product-specific contraindications are listed in each manufacturer's IFU and on the product page. Patient-specific factors (uncontrolled hyperglycemia, active substance use, non-adherence with offloading) are relative contraindications that should be addressed before graft application.

Question 19

How do I choose between sheet, particulate, or flowable formulations?

Accepted Answer

Choose by wound geometry and depth. Sheet grafts are best for wounds with a definable surface area and a flat or gently contoured bed — they maximize coverage per square centimeter and minimize wastage. Particulate formulations are designed for irregular, undermined, or tunneling wounds where a sheet cannot achieve full contact; they fill dead space and conform to complex geometry. Flowable formulations are designed for deep, narrow, or sinus-tract wounds and for instillation into spaces that a sheet or particulate cannot access. Many advanced wound centers stock all three formats from a single manufacturer to standardize handling.

Question 20

Is there published clinical data supporting the products you distribute?

Accepted Answer

Yes. Most of the products in our catalog have published RCTs, prospective cohort studies, and retrospective comparative effectiveness data in journals such as the International Wound Journal, Wounds, Journal of Wound Care, and Wound Repair and Regeneration. Each product page links to the relevant peer-reviewed evidence, FDA filings, and any HEOR data published by the manufacturer. Our clinical team can pull a tailored evidence packet for any product, indication, or payer-coverage discussion.

Question 21

How quickly can you deliver a graft after I place an order?

Accepted Answer

For in-stock products to most U.S. ZIP codes, we deliver next business day via overnight courier. Same-day delivery is available in most major metros for orders placed by mid-morning. For temperature-controlled products, we ship in validated cold-chain packaging with continuous temperature monitoring. Lead times for back-ordered products are quoted at the time of order.

Question 22

Do you offer same-day or next-day delivery?

Accepted Answer

Yes — next business day delivery is standard for in-stock orders placed by the daily cutoff. Same-day delivery is available in select metros with a cutoff that varies by city. STAT delivery for scheduled cases is also available — talk to your account representative to set up a standing STAT process for your practice.

Question 23

Can I set up consignment or trunk stock?

Accepted Answer

Yes — for higher-volume practices and wound centers we offer consignment arrangements on qualifying SKUs, with lot tracking, expiration management, and monthly reconciliation handled by our team. Trunk stock for rep-supported procedures is available on a case-by-case basis. Contact your account representative to scope a program that fits your usage and storage capacity.

Question 24

What sizes and configurations are available for each product?

Accepted Answer

Sheet allografts are typically stocked in a range of square sizes (1×1, 2×2, 2×3, 4×4, 4×6 cm and larger) and in disc and meshed configurations. Particulate and flowable products are stocked in standard volumetric sizes (e.g., 25 mg, 50 mg, 100 mg, 200 mg). Each product page lists every configuration with current Q-code and inventory status. If you need a configuration that is not stocked, we can usually source it within one to two business days.

Question 25

How do you handle returns or damaged shipments?

Accepted Answer

If a product arrives damaged, temperature-excursioned, or with a packaging integrity issue, notify us within 24 hours and we will replace it at no charge. Tissue products generally cannot be returned for credit once received and accepted, consistent with AATB and manufacturer policy. Unopened, in-date non-tissue products may be eligible for return per the manufacturer's return policy — we will coordinate.

Question 26

Is there a minimum order quantity?

Accepted Answer

No. We support single-unit, patient-specific orders for any product in our catalog. There is no minimum order quantity and no minimum account commitment.

Question 27

Can I order a single graft for a specific patient?

Accepted Answer

Yes. Most of our orders are patient-specific. You can place an order via the online quote sheet, by phone, or by fax with the patient initials/MRN, scheduled date of application, product, and ship-to address.

Question 28

Do you ship to the clinic, or to a hospital central supply?

Accepted Answer

Both. We ship to physician offices, wound care centers, ASCs, and hospital central receiving. For hospital deliveries we will follow your central supply receiving instructions (department contact, PO requirements, dock hours).

Question 29

How do you ensure cold chain integrity for temperature-sensitive grafts?

Accepted Answer

Temperature-controlled products are shipped in validated insulated containers with phase-change packs sized to the transit time and ambient profile, and include a continuous temperature data logger. On arrival, the data logger is reviewed and the chain-of-custody is recorded. If any excursion is detected, the product is quarantined and replaced.

Question 30

What information do I need to provide when placing an order?

Accepted Answer

For each order we need: the ordering provider name and NPI, the practice/facility ship-to address with a receiving contact, the product SKU and size, scheduled application date, patient initials and MRN (for traceability — no PHI required), and the billing pathway (insurance vs. cash). For first-time orders we also collect a signed account form, W-9, and resale or tax-exempt documentation where applicable.

Question 31

Are your graft products FDA-registered? Under what classification?

Accepted Answer

Yes. The amniotic tissue allografts we distribute are regulated by the FDA as Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) under 21 CFR Part 1271 Section 361, which requires registration of the tissue establishment, donor eligibility determination, and adherence to current Good Tissue Practices (cGTP). Synthetic and acellular dermal products in our catalog are regulated as 510(k)-cleared medical devices. Each product page lists its specific FDA pathway, establishment registration, and clearance number where applicable.

Question 32

Are your tissue products sourced from AATB-accredited tissue banks?

Accepted Answer

Yes. Every amniotic tissue product we distribute is processed by an AATB-accredited tissue bank. AATB accreditation requires adherence to standards that exceed FDA minimums, including donor screening, recovery, processing, packaging, storage, and distribution controls. Certificates of accreditation for each tissue partner are available on request.

Question 33

How do you ensure donor screening and serological testing?

Accepted Answer

Tissue partners follow donor eligibility determination per 21 CFR 1271 Subpart C, which includes medical and social history review, physical assessment, and FDA-mandated serological testing for HIV-1/2, HBV, HCV, HTLV-I/II, syphilis, and (where applicable) WNV, CMV, and Zika. Birth tissue products additionally screen for chorioamnionitis and other peripartum risk factors. Donor eligibility documentation accompanies every product and is available on request.

Question 34

Do products fall under Section 361 HCT/P or require 510(k) clearance?

Accepted Answer

Amniotic membrane allografts intended for homologous use, minimally manipulated, and not combined with another article are regulated as Section 361 HCT/Ps and do not require premarket clearance. Acellular dermal matrices, synthetic substitutes, and most collagen-based products are regulated as medical devices and have 510(k) clearance. The regulatory pathway is listed on every product page along with the corresponding FDA documentation.

Question 35

Can you provide a Certificate of Analysis or Conformance?

Accepted Answer

Yes. Certificates of Analysis (CoA) and Certificates of Conformance (CoC) are available for every lot we distribute, on request and at no charge. For audited facilities and 340B contracting, we can establish a standing CoA delivery process so documentation accompanies every shipment.

Question 36

What lot traceability and recall processes do you have?

Accepted Answer

Every unit shipped is recorded in our system against the receiving facility and the application case (where provided), so we can trace any lot from manufacturer through application within minutes. We maintain a written recall SOP aligned with 21 CFR 1271.290 and the AATB Recall Standard. In the event of a manufacturer or FDA recall, affected customers are notified by phone and in writing within 24 hours with instructions for quarantine, return, and replacement.

Question 37

What is a wound graft, and how does it help my wound heal?

Accepted Answer

A wound graft is a thin layer of specially prepared tissue or material that your provider places over a wound that has been slow to heal on its own. Many of the grafts used today come from donated amniotic membrane — the natural tissue that surrounds a baby during pregnancy — which is rich in proteins that help your body's own healing process restart. The graft acts like a "biological bandage" that protects the wound, reduces inflammation, and signals your body to grow new healthy tissue. Most patients begin to see real progress within a few weeks of starting graft treatment. Always follow your provider's specific instructions for your healing plan.

Question 38

Where does the graft tissue come from?

Accepted Answer

Most amniotic grafts come from healthy mothers who choose to donate the placenta and amniotic membrane after a scheduled, full-term, healthy cesarean birth. The tissue is donated voluntarily — it would otherwise be discarded — and the donation never affects the mother or baby. Every donor is carefully screened for medical history and tested for infectious diseases before any tissue is used. Synthetic and collagen-based grafts are made in a controlled laboratory setting. Your provider will explain exactly which type of graft is being used for your healing.

Question 39

Is the graft safe? How is the tissue screened and tested?

Accepted Answer

Yes. Tissue grafts in the United States are regulated by the FDA and processed by tissue banks accredited by the American Association of Tissue Banks (AATB). Every donor is screened against strict medical and social history criteria and tested for infectious diseases including HIV, hepatitis B and C, syphilis, and others. The tissue is then processed and packaged under sterile conditions and tracked by lot number from donor through delivery. The safety record for amniotic tissue grafts is excellent. If you have any concerns, your provider can answer specific questions about the product they plan to use.

Question 40

What's the difference between amniotic, collagen, and synthetic grafts?

Accepted Answer

Amniotic grafts come from donated birth tissue and contain natural proteins (called growth factors) that help your body restart its healing process — they are often used for wounds that have been stuck or slow to close. Collagen grafts are made from purified animal collagen and act as a scaffold that supports new tissue growth. Synthetic grafts are made from man-made materials and provide a protective covering while your body heals underneath. Each type has a role, and your provider will choose the one best suited to your wound and overall health. Always follow your provider's specific recommendations.

Question 41

Will my body reject the graft?

Accepted Answer

True rejection — like what can happen with an organ transplant — is extremely rare with amniotic and collagen wound grafts. Amniotic tissue is what doctors call "immune-privileged," which means your body generally does not see it as foreign. Most of the time the graft is gradually absorbed and replaced by your own healing tissue. If a graft does not take well, your provider will simply place a new one or adjust the treatment plan. Mild redness or warmth at the wound is normal in the first day or two — call your provider if you notice anything you are unsure about.

Question 42

How long does it take for a wound to heal with a graft?

Accepted Answer

Most chronic wounds treated with grafts show clear improvement within 4 to 6 weeks, with complete healing often taking 8 to 16 weeks depending on the wound size, location, and your overall health. Some wounds heal faster, and some — especially in patients with diabetes, poor circulation, or other health challenges — take longer. The key is that the graft re-starts a healing process that had stalled. Your care team will measure and photograph your wound at each visit so you can see the progress.

Question 43

Is the procedure painful?

Accepted Answer

For most patients, applying a wound graft is no more uncomfortable than a typical dressing change. Your provider may clean and gently debride (remove dead tissue from) the wound first, which can be briefly uncomfortable — local numbing medicine is often used to help. Placing the graft itself usually causes little to no discomfort because the graft is thin and soft. Many patients actually feel less wound pain in the days after a graft is placed because the graft protects the exposed nerves in the wound bed. Tell your provider right away if you have pain that surprises you.

Question 44

How many graft applications will I need?

Accepted Answer

Most patients receive a graft about once a week until the wound is fully healed — typically somewhere between 3 and 10 applications in total. Some wounds close in just a few applications; others, especially deeper or more complex wounds, take more. Your provider will reassess your wound at every visit and only continue applications as long as the wound is responding. Always follow your provider's specific recommendations for your healing plan.

Question 45

Will Medicare or my insurance cover the wound graft?

Accepted Answer

In most cases, yes. Medicare and most major insurance plans cover wound grafts for chronic wounds such as diabetic foot ulcers and venous leg ulcers when other treatments have not worked. Coverage rules vary by plan and by region, so your provider's office will typically verify your benefits before the first application. If you have a Medicare Advantage or commercial plan, prior authorization may be required. We are happy to help your provider's office check your specific coverage before treatment begins.

Question 46

What if my insurance denies coverage?

Accepted Answer

A denial does not always mean the end of the road. Many initial denials are reversed on appeal once additional documentation is submitted — for example, photos and measurements showing that other treatments were tried first. Your provider's office can file an appeal, and our reimbursement team is available to help them prepare the supporting paperwork. If coverage cannot be obtained, your provider can talk with you about other treatment options. Always follow up with your provider's billing team if you receive a denial letter.

Question 47

Will I have any out-of-pocket costs?

Accepted Answer

That depends on your specific insurance plan. With traditional Medicare Part B, most patients owe the standard 20% coinsurance after the deductible, which is often picked up by a supplemental ("Medigap") plan. Medicare Advantage and commercial plans have their own copays, deductibles, and out-of-pocket maximums. Your provider's billing team can give you a personalized estimate before treatment begins. If cost is a concern, please tell your provider — there are often options to help.

Question 48

Does my doctor need prior authorization before using a graft?

Accepted Answer

It depends on your insurance plan. Traditional Medicare typically does not require prior authorization for skin substitute grafts, but Medicare Advantage and most commercial plans do. Your provider's office will handle the prior authorization paperwork for you — they may ask you for documentation of past treatments or recent visits to other doctors. The process usually takes a few days to a couple of weeks. Always follow your provider's office's instructions about scheduling.

Question 49

What happens if Medicare doesn't cover the full amount?

Accepted Answer

Medicare typically covers 80% of the approved amount for wound grafts in a physician office setting after you have met your Part B deductible. The remaining 20% may be covered by a Medicare Supplement (Medigap) policy, by Medicaid if you qualify, or by your secondary insurance. If you do not have secondary coverage, you may be responsible for the coinsurance — your provider's billing team will help you understand the amount in advance. Never hesitate to ask about payment options if cost is a concern; many practices have plans to help.

Question 50

How should I prepare for my graft appointment?

Accepted Answer

Wear loose, comfortable clothing that gives easy access to the wound. Keep the existing dressing in place unless your provider has told you otherwise. Bring a list of all the medications you take (including blood thinners), and let the office know in advance if you have taken pain medication, eaten recently, or have any allergies. If your wound is on your foot or leg, consider arranging for a driver if you typically use an offloading boot. Always follow any specific instructions your provider's office gives you.

Question 51

What happens during the graft application?

Accepted Answer

Your provider will first clean the wound and gently remove any dead tissue (a process called debridement) so the graft can make good contact with healthy tissue underneath. Numbing medicine may be used if needed. The graft is then trimmed to fit the wound and placed directly on the wound bed. A protective dressing is applied to hold the graft in place and keep it moist as it begins to integrate. The whole visit usually takes 20–45 minutes.

Question 52

What should I do (and not do) after the graft is applied?

Accepted Answer

Keep the dressing clean, dry, and in place exactly as your provider instructed. Avoid putting pressure on the wound — if it is on your foot, wear your offloading boot at all times when standing or walking. Do not remove or peek under the dressing unless your provider tells you to. Avoid soaking the wound (no baths, swimming, or hot tubs) until cleared. Take any prescribed medications, eat well, stay hydrated, and call your provider if anything feels off. Always follow your provider's specific instructions.

Question 53

What are the signs of healthy healing?

Accepted Answer

Good signs include the wound getting visibly smaller over time, the edges becoming smoother and pinker, less drainage, and less pain. You may also notice new pink tissue (called granulation) forming in the wound bed — that is healthy new tissue growing. Some mild itching as the wound heals is normal. Your care team will measure the wound at every visit so you can track progress.

Question 54

What are the warning signs that something is wrong?

Accepted Answer

Call your provider promptly if you notice: increasing pain, redness, swelling, or warmth around the wound; pus, foul odor, or unusual drainage; fever or chills; the wound getting larger instead of smaller; or the dressing becoming soaked, loose, or dislodged. If you have diabetes or poor circulation, do not wait — call sooner rather than later. When in doubt, call your provider. It is always better to check than to wait.

Question 55

Can I shower or get the graft wet?

Accepted Answer

Usually not in the first few days after a graft is placed. Most providers ask you to keep the dressing dry until your next visit, then give you specific instructions for showering with a waterproof cover. Soaking the wound (baths, pools, hot tubs) is generally avoided until the wound is fully healed. Always follow your provider's specific instructions — they may differ based on where the wound is and how it is healing.

Question 56

Do I need to wear a special boot or offloading device?

Accepted Answer

If your wound is on your foot or heel, almost certainly yes. Offloading — taking pressure off the wound — is one of the single most important things you can do to help a foot wound heal. Your provider may give you a removable cast walker boot, a total contact cast, or special inserts. Wear the device exactly as instructed, including for short trips to the bathroom or kitchen. Skipping the boot, even briefly, can undo days or weeks of healing.

Question 57

How often will I need follow-up appointments?

Accepted Answer

Most patients are seen weekly during graft treatment so the wound can be measured, photographed, and reassessed, and a new graft applied if needed. Once the wound is closed, your provider may transition you to less frequent visits to make sure the healing holds. Keeping every appointment matters — small adjustments along the way are what get the wound across the finish line.

Question 58

What can I do at home to support wound healing?

Accepted Answer

The big four are: keep the dressing intact and the wound protected; wear your offloading device exactly as instructed; eat well — especially protein, vitamin C, and zinc; and manage any underlying conditions like diabetes (keep your blood sugar in your target range) and high blood pressure. Avoid smoking and limit alcohol, both of which slow healing significantly. Gentle movement is usually good; ask your provider what activity is safe for you.

Question 59

Why do chronic wounds take so long to heal?

Accepted Answer

Healthy wounds heal through a series of overlapping stages — inflammation, new tissue growth, and remodeling. In a chronic wound, that process gets "stuck," often in the inflammation stage, because of poor blood flow, infection, repeated pressure, uncontrolled blood sugar, or other factors. The wound is not lazy and you have not done something wrong — it is a medical problem that needs the right combination of treatments to restart healing. Modern wound grafts work by giving your body the signal to move out of that stuck phase.

Question 60

What conditions raise my risk for a non-healing wound?

Accepted Answer

The biggest risk factors are diabetes, poor circulation (peripheral artery disease), venous insufficiency, prolonged pressure (especially in people with limited mobility), prior wounds in the same area, smoking, poor nutrition, certain medications such as long-term steroids, and conditions that weaken the immune system. Aging also makes wounds heal more slowly. The good news: most of these factors can be managed, and even small improvements (better blood sugar, quitting smoking, taking pressure off the wound) make a big difference.

Question 61

How can I prevent future wounds after this one heals?

Accepted Answer

Inspect your skin daily — especially your feet if you have diabetes or neuropathy — and look for redness, blisters, or breaks. Wear well-fitting shoes and never go barefoot outdoors. Keep your skin moisturized but dry between the toes. Manage your blood sugar, blood pressure, and weight. Keep up with podiatry and vascular follow-ups. If you had a venous leg ulcer, wear your compression stockings exactly as prescribed — it is the single most important step to prevent recurrence.

Question 62

What should I eat to support wound healing?

Accepted Answer

Your body needs extra "building blocks" to heal. Focus on protein at every meal (chicken, fish, eggs, beans, Greek yogurt), plenty of fruits and vegetables (especially those rich in vitamin C like citrus and bell peppers), and foods with zinc (lean meat, nuts, whole grains). Stay well hydrated with water. If you have diabetes, work with your provider or dietitian to keep carbohydrates balanced so your blood sugar stays in range. If your appetite is low, smaller frequent meals or a nutritional supplement drink can help — ask your provider.

Question 63

Does smoking affect wound healing?

Accepted Answer

Yes, significantly. Smoking narrows blood vessels and reduces the oxygen delivered to your wound, both of which slow healing dramatically. Patients who quit smoking — even just for the duration of treatment — heal noticeably better. If you would like help quitting, ask your provider; there are medications and support programs that work, and quitting at any age improves your healing and overall health.

Question 64

How does diabetes affect wound healing, and why is foot care so important?

Accepted Answer

Diabetes can affect wound healing in three big ways: high blood sugar slows the immune response, reduced circulation limits oxygen delivery, and nerve damage (neuropathy) means you may not feel a small injury before it becomes a serious wound. That is why daily foot inspection, well-fitting shoes, regular podiatry visits, and tight blood-sugar control are so important. A small foot wound caught early heals far more easily than one discovered late. If you have diabetes and notice any break in the skin on your foot, contact your provider promptly.

Wound Graft FAQ: Answers for Providers & Patients

For Healthcare Providers

For Patients & Caregivers

Understanding Wound Grafts

Insurance & Cost

What to Expect During Treatment

General Wound Care Knowledge

About Kindr Wound Care

Who is Kindr Wound Care?

What territories do you serve?

How do you differ from other wound graft distributors?

How do I become a referring provider or set up an account?

Do you work with home health agencies and skilled nursing facilities?

Still Have Questions?